Humans have fear responses resulting from a great number of factors, including genetic, prenatal, nutritional and over-stimulation. However, unlike animals, humans have additional fear responses to a great number of lifestyle factors, including, rejection, "baggage" & covert fears, negative media and loss of "alpha-dog" social status. These "emotional/social" fears often result in increased anxiety, insomnia & aggression and take a toll on the body and adrenals, mind and relationships. Arousal disorders strongly influence neurotransmitters, EEG activity and subsequent cognitive ability and emotional behavior.

Arousal is reflected fairly well in brain wave activity and is observable in the classic QEEG. We will review several QEEGs and see the brain signature of: 3 types of anxiety, depression, stress, obsessive compulsive disorder, and ADHD. We will also see pre-post AVE results of brain activity for various ailments.

HRV reflects are our immediate state of arousal with each and every heartbeat. We will learn about HRV as viewed on the "M-Wave" and review some clinical cases involving depression, anxiety and trauma with pre/post AVE outcomes. Following the lecture will be a practice session, where the attendees will learn to breathe in pace with the heartbeat that is played on the DAVID units.

Roughly 130 studies have been published on CES. Most of the roughly 130 studies have shown CES as a reliable method to reduce anxiety, depression, pain, improve sleep, and improve cognition and IQ.

In this module, we will learn how to use the DAVID products so that the attendee can experience them overnight.

In 43 to 48 AD, Scribonius Largus, the physician of Roman emperor Claudius, observed that placing a large torpedo fish (electric eel) over the scalp of a patient suffering with headache, elicited a sudden transient stupor with pain relief. A major advantage of tDCS is that the cortical activity over a specific site on the brain may be enhanced or suppressed, much like NF. Dozens of studies on, tDCS have been published to date. Transcranial DC Stimulation is the application of an anode (+ve) or cathode (-ve) electrode to enhance or inhibit brain activity under the electrode by influencing glial-cell activity. Approximately 80 studies of all kinds exist on the topic, which will be reviewed as well as information on electrode size, amperage used, current density and electrode placement.

Since the discovery of photic driving by Adrian and Matthews in 1934, much has been discovered about the benefits of brainwave entrainment (BWE) or audio-visual entrainment (AVE), as it is often called today. The first clinical applications of AVE are the credit of Kroger & Schneider who developed the first photic stimulation device called the Brain Wave Synchronizer in 1958 and prompted the first research. AVE affects cerebral blood flow, neurotransmitters, dissociative states and brainwave activity. Research on the effectiveness of AVE in promoting relaxation, cognition & memory, hypnotic induction, and in treating ADD, PMS, SAD, PTSD, migraine headache, chronic pain, anxiety, depression, insomnia is now available.

Studies have shown that AVE is quite effective for reducing the symptoms of ADD/ADHD without undesirable side-effects, and better results than stimulant drugs. AVE also shows promise to outperform neurofeedback. The results from these studies will be revealed.

Several factors must be considered when designing an AVE session. These factors will be reviewed and the typical sessions used on the DAVID products will be revealed.

We will draw up a session the DAVID Session Editor and program it into a Pal or Delight device and play it back to verify that the session follows the Editor.